Strategic Research Institute Release: The World Antibody Community To Convene At Antibody Manufacturing & Production Conference June 12-14, 2006 In San Francisco, CA

SAN FRANCISCO, April 27 /PRNewswire/ -- The world antibody community will convene on June 12-14, 2006 in San Francisco to attend and network at the "Antibody Manufacturing & Production" conference, part of AWS, announces Strategic Research Institute.

The 2006 Antibody World Summit (AWS) features 3 concurrent conferences that permit attendees to choose among 3 sessions at any time, tripling the session options, networking opportunities, and attendance. Those attending will have opportunity to learn about the latest in antibody technologies, discovery & development, manufacturing & production, therapeutics and partnering issues from the industrial, academic, and financial communities.

The featured conference track on ANTIBODY MANUFACTURING & PRODUCTION attracts a very broad and international constituency of pharma/biotech companies, antibody companies and companies involved in the manufacturing and production of therapeutic antibodies. Companies such as Amgen, Genentech, Pfizer, Biogen Idec, Merck Research Laboratories, GlaxoSmithKline, Centocor, Eli Lilly & Company, Medarex, Human Genome Sciences, CellGenesys, Sangamo Biosciences and others will be presenting the latest in antibody manufacturing, cell culture & production, recovery & purification, analytical and product characterization, cell line selection and expression enhancement as well as conjugation and formulation.

The featured Antibody Manufacturing keynote presentations include: - Moving Toward the Next Generation of Biopharmaceutical Manufacturing by Paul Marshall, VP of Corporate Development Manufacturing, Amgen - Biogen Idec's 15.000 L Manufacturing Experience Based on Successful Process Development and Tech Transfer by Wolfgang Noe, VP, Bioprocess Development, Biogen Idec - Formulation & Drug Delivery Issues in Biopharmaceutical Manufacturing by Narendra Bam, VP of Biopharmaceutical Development, GlaxoSmithKline Pharmaceuticals The 2006 AWS features 3 concurrent conferences on - Antibody Discovery & Development - mAbs in Oncology - Antibody Manufacturing & Production

To request a copy of the agenda in PDF format or for additional information, please contact Glenn Pascual at gpascual@srinstitute.com or call 212-967-0095 x245. Please include your name, title and full contact info.

For more information on how to present a poster at AWS, please contact Glenn Pascual at gpascual@srinstitute.com.

For more information on sponsorship & exhibition opportunities to augment your company's on-site exposure to prospective clients and collaborators, please contact Mark Alexay at malexay@srinstitute.com.

For more information on how to become a media partner, please contact Cheryl Kahan-Radhuber at ckahan-radhuber@srinstitute.com.

Strategic Research Institute

CONTACT: Glenn Pascual, gpascual@srinstitute.com, +1-212-967-0095 x245, orMark Alexay, malexay@srinstitute.com, or Cheryl Kahan-Radhuber,ckahan-radhuber@srinstitute.com, all of Strategic Research Institute

MORE ON THIS TOPIC